Details

Autor(en) / Beteiligte

• Kar, Shantanu K
• Pach, Alfred
• Sah, Binod
• Kerketta, Anna S
• Patnaik, Bikash
• Mogasale, VijayaLaxmi
• Kim, Yang Hee
• Rath, Shyam Bandhu
• Shin, Sunheang
• Khuntia, Hemant K
• Bhattachan, Anuj
• Puri, Mahesh K
• Wierzba, Thomas F
• Kaljee, Linda M

Titel

Uptake during an oral cholera vaccine pilot demonstration program, Odisha, India

Ist Teil von

• Human vaccines & immunotherapeutics, 2014-10, Vol.10 (10), p.2834-2842

Ort / Verlag

United States: Taylor & Francis

Erscheinungsjahr

2014

Link zum Volltext

Quelle

MEDLINE

Beschreibungen/Notizen

• Approximately 30% of reported global cholera cases occur in India. In 2011, a household survey was conducted 4 months after an oral cholera vaccine pilot demonstration project in Odisha India to assess factors associated with vaccine up-take and exposure to a communication and social mobilization campaign. Nine villages were purposefully selected based on socio-demographics and demonstration participation rates. Households were stratified by level of participation and randomly selected. Bivariate and ordered logistic regression analyses were conducted. 517/600 (86%) selected households were surveyed. At the household level, participant compared to non-participant households were more likely to use the local primary health centers for general healthcare (P < 0.001). Similarly, at the village level, higher participation was associated with use of the primary health centers (P < 0.001) and private clinics (p = 0.032). Also at the village level, lower participation was associated with greater perceived availability of effective treatment for cholera (p = 0.013) and higher participation was associated with respondents reporting spouse as the sole decision-maker for household participation in the study. In terms of pre-vaccination communication, at the household level verbal communication was reported to be more useful than written communication. However written communication was perceived to be more useful by respondents in low-participating villages compared to average-participating villages (p = 0.007) These data on participation in an oral cholera vaccine demonstration program are important in light of the World Health Organization's (WHO) recommendations for pre-emptive use of cholera vaccine among vulnerable populations in endemic settings. Continued research is needed to further delineate barriers to vaccine up-take within and across targeted communities in low- and middle-income countries.